日本語
TOP page
Published papers
Academic conference presentation
(Last updated : 2025-11-21 11:01:54)
MIZOGUCHI Shinsuke
Department
Other, Other Department of Urology
Position
■
Published papers
1.
Original article
Long-term real-world outcomes of nivolumab plus ipilimumab for advanced renal cell carcinoma: a minimum of 4-years follow-up study. 2025/09
2.
Case report
Case Report: complete response to preoperative ipilimumab and nivolumab combination therapy in advanced papillary renal cell carcinoma with inferior vena cava tumor thrombus and multiple metastases. 2025/08
3.
Original article
Effect of age on treatment outcomes of first-line immune checkpoint inhibitor combination therapy for previously untreated advanced renal cell carcinoma. 2025/08
4.
Other
Impact of cytoreductive nephrectomy on immune checkpoint inhibitor therapy: Treatment outcomes of immune inhibitors combination therapies for metastatic renal cell carcinoma with primary kidney tumors. 2025/05
5.
Original article
Comparative analysis of outcomes for patients with advanced renal cell carcinoma: Immuno-oncology era versus tyrosine kinase inhibitor era in the IMDC favorable-risk group. 2025/04
6.
Original article
Safety and efficacy of enfortumab vedotin for locally advanced or metastatic urothelial carcinoma in patients aged 80 years and older: A multicenter retrospective study in Japan. 2025/04
7.
Original article
Changes in outcome of patients with advanced non‑clear cell renal cell carcinoma from the tyrosine kinase inhibitor era
to the immuno‑oncology era. 2024/11
8.
Original article
Robot-assisted partial nephrectomy for multiple allograft renal cell carcinomas: A case report. 2024/11
9.
Original article
Prognostic impact of the administration of antibiotics and proton pump inhibitors in immune checkpoint inhibitor combination therapy for advanced renal cell carcinoma. 2024/07/03
10.
Original article
Robot-assisted partial nephrectomy with selective artery clamping for renal cell carcinoma in horseshoe kidney. 2024/07
11.
Original article
Survival impact of glucocorticoid administration for adverse events during immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma. 2024/07
12.
Case report
Advanced renal cell carcinoma with Inferior vena cava thrombus treated with a combination of preoperative lenvatinib and pembrolizumab. 2024/03
Display 5 items
Display all(12)
■
Academic conference presentation
1.
Immunotherapy outcomes and immune microenvironment profiles of patients with non-clear cell renal cell carcinoma. (Poster notice,General) 2025/09/26
2.
Impact of cytoreductive nephrectomy on immunecheckpoint inhibitor therapy: Treatment outcomes of immune inhibitors combination therapies formetastatic renal cell carcinoma with primary kidneytumors. (Poster notice,General) 2025/04/28
3.
BRCA mutation-positive prostate cancer at our hospital initial experience with olaparib in BRCA mutation-positive prostate cancer. (Poster notice,General) 2024/04/26
4.
Efficiency of IO-IO combination therapy and IO-TKI combination therapy for renal cell carcinoma with inferior vena cava tumor thrombus. (Poster notice) 2024/04/26
5.
Utility of whole-body MRI (DWIBS) in treatment decision-making for M0CRPC: A case series study. (Poster notice,General) 2024/04/26
6.
Comparison of Perioperative Outcomes between Robot-Assisted Laparoscopic Radical Nephroureterectomy and Laparoscopic Radical Nephroureterectomy. (Poster notice) 2024/04/25
7.
Comparison of surgical outcomes between robot-assisted and conventional laparoscopic adrenalectomy at Tokyo Women's Medical University Hospital. (Poster notice,General) 2024/04/25
8.
Evaluation of cases of cytomegalovirus infection after renal transplantation at our department. (Speech,General) 2022/11/25
Display 5 items
Display all(8)